You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 7, August 19, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •CME Course for This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Quality of Care
 •Quality of Care, Other
 •Prognosis/ Outcomes
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy
 •Drug Therapy, Other
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CLINICIAN'S CORNER
Heart Failure Performance Measures and Outcomes

Real or Illusory Gains

Gregg C. Fonarow, MD; Eric D. Peterson, MD, MPH

JAMA. 2009;302(7):792-794.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Heart failure is one of the most deadly and costly conditions in the United States.1 Among Medicare beneficiaries, heart failure is the most frequent cause of hospitalization and death, with 1-year readmission and mortality rates of 65% and 35%, respectively.2 While a number of therapies and interventions have been demonstrated to improve heart failure outcomes,1 studies have consistently shown gaps, variations, and disparities in the application of these therapies in routine clinical practice.3

In 1996, the Centers for Medicare & Medicaid Services (CMS) first implemented a program to track and improve the quality of heart failure care in hospitals. The CMS subsequently aligned with The Joint Commission to create a national standardized "core" set of 4 heart failure performance metrics: measuring left ventricular function; using angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction; providing complete heart failure . . . [Full Text of this Article]

Author Affiliations: Ronald Reagan UCLA Medical Center, Los Angeles, California (Dr Fonarow); Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina (Dr Peterson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.